Yale University Purchases Sequenom MassARRAY Platform
News May 13, 2008
Sequenom, Inc. has announced the purchase by the W.M. Keck Foundation Biotechnology Resource Laboratory at Yale University of Sequenom's MassARRAY® system.
Yale plans to use the system as a platform for genotyping, copy number variation (CNV), methylation and quantitative gene expression (QGE) applications.
"The W.M. Keck Foundation Biotechnology Resource Laboratory is a highly respected institution, making this a particularly important placement," said Mike Monko, SEQUENOM'S Senior Vice President, Sales and Marketing.
"The MassARRAY system's ability to provide multiple applications for genetic research on a single platform has promoted the placement of our platform into almost all major university core laboratories."
Shrikant M. Mane, Ph.D., Director of Microarray Resources at the W.M. Keck Facility, stated, "Service requests from Yale researchers as well as other third-party organizations have significantly increased, prompting our purchasing decision. After conducting a thorough analysis of competing platforms in the gene- and whole-genome and fine-mapping and validation genetic analysis markets, we chose Sequenom's MassARRAY technology as the platform that best suits our numerous requirements."
Pre-Filled Syringes & Injectable Drug Devices Europe
Jan 16 - Jan 17, 2019
3rd International Conference and Exhibition on Nanomedicine and Drug Delivery
Mar 13 - Mar 14, 2019
International Conference on Cell and Structural biology
Jul 15 - Jul 16, 2019